274 related articles for article (PubMed ID: 31990046)
1. The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.
Servaas NH; Spierings J; Pandit A; van Laar JM
Clin Exp Immunol; 2020 Jul; 201(1):34-39. PubMed ID: 31990046
[TBL] [Abstract][Full Text] [Related]
2. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
3. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
4. Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?
van Rhijn-Brouwer FCC; Spierings J; van Laar JM
Immunol Lett; 2018 Mar; 195():88-96. PubMed ID: 29155233
[TBL] [Abstract][Full Text] [Related]
5. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
Ruder J; Rex J; Obahor S; Docampo MJ; Müller AMS; Schanz U; Jelcic I; Martin R
Front Immunol; 2021; 12():794077. PubMed ID: 34975899
[TBL] [Abstract][Full Text] [Related]
6. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
8. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
[TBL] [Abstract][Full Text] [Related]
9. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
[TBL] [Abstract][Full Text] [Related]
10. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
[TBL] [Abstract][Full Text] [Related]
11. Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients.
Strunz PP; Froehlich M; Gernert M; Schwaneck EC; Fleischer A; Pecher AC; Tony HP; Henes JC; Schmalzing M
Front Immunol; 2021; 12():723349. PubMed ID: 34539659
[TBL] [Abstract][Full Text] [Related]
12. Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.
Arruda LCM; Malmegrim KCR; Lima-Júnior JR; Clave E; Dias JBE; Moraes DA; Douay C; Fournier I; Moins-Teisserenc H; Alberdi AJ; Covas DT; Simões BP; Lansiaux P; Toubert A; Oliveira MC
Blood Adv; 2018 Jan; 2(2):126-141. PubMed ID: 29365321
[TBL] [Abstract][Full Text] [Related]
13. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation.
Broens B; van der Laken CJ; Zwezerijnen GJC; Nossent EJ; Meijboom LJ; Spierings J; de Vries-Bouwstra JK; van Laar JM; Voskuyl AE
Front Immunol; 2022; 13():923869. PubMed ID: 35865521
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
Front Immunol; 2018; 9():834. PubMed ID: 29867923
[TBL] [Abstract][Full Text] [Related]
15. Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
Dulko AJ; Butrimiene I; Cypiene A; Peceliunas V; Petroska D; Stankeviciene E; Rugiene R
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541223
[TBL] [Abstract][Full Text] [Related]
16. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
Arruda LC; Clave E; Moins-Teisserenc H; Douay C; Farge D; Toubert A
Curr Res Transl Med; 2016; 64(2):107-13. PubMed ID: 27316394
[TBL] [Abstract][Full Text] [Related]
17. Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.
Farge D; Arruda LC; Brigant F; Clave E; Douay C; Marjanovic Z; Deligny C; Maki G; Gluckman E; Toubert A; Moins-Teisserenc H
J Hematol Oncol; 2017 Jan; 10(1):21. PubMed ID: 28103947
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease.
Strunz PP; Labinsky H; Nagler LK; Portegys J; Froehlich M; Gernert M; Schmalzing M
Front Immunol; 2023; 14():1294496. PubMed ID: 38045701
[TBL] [Abstract][Full Text] [Related]
19. Stem cell therapies for systemic sclerosis.
Cipriani P; Ruscitti P; Giacomelli R
Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
[TBL] [Abstract][Full Text] [Related]
20. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]